WHO lists groups of people most 'at risk' of breast cancer

The World Health Organization (WHO) has identified specific groups of individuals who are at heightened risk of developing breast cancer, emphasizing the importance of awareness regarding risk factors and symptoms. According to recent reports, the organization highlights that while being female is the primary risk factor, accounting for nearly all cases, the presence of additional factors can significantly elevate the likelihood of contracting the disease. The WHO's findings come amid growing public concern following the announcement by British actress Lucy Davis, 53, who disclosed her diagnosis with incurable stage 4 breast cancer. In a heartfelt message shared via social media, Davis expressed her acceptance of the situation, stating she was at peace with whatever lay ahead. Her revelation underscores the urgency of understanding the risks associated with breast cancer and recognizing its symptoms early. Breast cancer, as defined by the WHO, involves uncontrolled growth of abnormal cells within the breast, potentially leading to tumor formation. These tumors can spread beyond the breast to other areas of the body, posing serious health threats. Initially, breast cancer typically originates in the milk ducts or lobules responsible for producing milk. Early-stage cancer, referred to as in situ, is non-life-threatening and detectable in its initial phases. However, once cancer becomes invasive, it can spread to adjacent tissues, creating palpable lumps or thickening. Invasive breast cancers pose a greater threat due to their potential to metastasize, spreading to nearby lymph nodes or distant organs. Treatment approaches vary depending on individual circumstances, including the cancer's type and progression stage. Options may involve surgical interventions, radiation therapy, and pharmacological treatments tailored to each patient's condition. The WHO identifies several key risk factors contributing to breast cancer susceptibility. Being female constitutes the most significant risk factor, with approximately 99% of cases occurring in women. Men account for roughly 0.5–1% of diagnoses. Additional risk elements encompass increasing age, obesity, excessive alcohol consumption, familial history of breast cancer, prior radiation exposure, reproductive patterns such as the onset of menstruation and age at first childbirth, tobacco usage, and postmenopausal hormone therapy. According to the WHO, about 80% of breast cancer instances occur in women lacking modifiable risk factors besides gender and age above 40. While a family history of breast cancer heightens the risk, many diagnosed women lack such a background. Absence of a known family history does not guarantee reduced risk, indicating that other variables might contribute to disease development. Genetic predispositions play a crucial role in determining breast cancer risk. Specific inherited gene mutations, particularly in BRCA1, BRCA2, and PALB-2, substantially increase susceptibility. Individuals identified with these genetic alterations or deemed high-risk should explore preventive measures such as chemoprevention or bilateral mastectomy to mitigate chances of developing the disease. Recognizing the signs of breast cancer is essential for timely intervention. Common indicators include the presence of a breast lump or thickening, often painless, along with noticeable changes in breast size, shape, or appearance. Skin alterations such as dimpling, redness, or pitting may also signal the condition. Changes affecting the nipple or surrounding area, including discharge or blood, warrant immediate attention. Discovering an unusual breast lump necessitates prompt medical evaluation, as early detection enhances treatment success rates. Although most lumps are benign, identifying cancerous growths at an early stage improves prognosis by enabling earlier intervention before the disease progresses to affect nearby lymph nodes or other bodily regions.